Defining health and economic burden of Invasive Meningococcal Disease (IMD) in Canada is critical to inform Public Health Policy around immunization programs. A comprehensive literature review was conducted to assess available studies, a lack of comprehensive Canadian data to allow evaluation of total economic burden of IMD was identified in Canada. Thus, this dissertation proposes a prospective cost collection methodology tailored to Canadian data and healthcare utilization (HCU). All patient-related HCU is considered and outlined. HCU is then categorized as direct or indirect and relevant direct and indirect healthcare costs are detailed. Intangible costs are described and methodology for capturing these costs using validated quality of life instruments is proposed. As all published economic evaluations of this disease lack prospective collection of data, this study proposes the use of a patient diary to serve as a memory aid during patient cost-collection interviews.